Delivery Order SPE2DB20D3101-SPE2DB23FRPK5
- Not listed
- This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,904.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
- This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules, a cardiovascular medication, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,608.17, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of May 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,657.92 Firm Fixed Price Delivery Order is for the supply of Icosapent Ethyl 1 gram capsules, a prescription medication, with a period of performance through August 16, 2024. The award is not associated with a set-aside program. As a significant federal contractor, Amerisourcebergen provides a wide range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,871.58 firm fixed-price delivery order is for the supply of 120-count capsules of the drug Icosapent Ethyl 1 gram. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 18, 2024. The $20,757.04 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,656.98, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 24, 2023. It is not associated with a set-aside designation. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Icosapent Ethyl 1 Gram Capsule 120s, a pharmaceutical product. The contract is a firm fixed price Delivery Order with a ceiling value of $2,772.28 and a period of performance through May 30, 2025. The contract is not set aside and is awarded as an open competition. Amerisourcebergen...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,229.78 for the pharmaceutical product Icosapent Ethyl 1 gram capsules. The contract was awarded by the Defense Logistics Agency (DLA) on January 20, 2023, with a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
- This federal contract award, valued at $1,248.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) for the supply of Icosapent Ethyl 1 gram capsules. The contract is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which runs through November 2026. This IDC...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRPK5Delivery Order
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,719.57 and is a firm fixed-price delivery order with a completion date of June 15, 2023. The award is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a larger pharmaceutical distribution company that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00, respectively. These IDCs enable the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 6/14/23 |